Expert insights, guides, and stories about health 
The article’s time-sensitive claims regarding Hello Heart’s recognition, Olive AI’s collapse, Babylon Health’s challenges, and Pear Therapeutics’ struggles are accurate and up-to-date as of July…
The healthcare AI landscape, frequently lauded for its transformative potential, often generates significant buzz around technological breakthroughs, funding rounds, and media accolades. Yet, for investors…
In the burgeoning landscape of AI in healthcare, the true measure of innovation extends far beyond technological sophistication or funding rounds. For health plan executives…
In the high-stakes arena of healthcare AI, the distinction between technological novelty and demonstrable clinical impact often defines true innovation. Our scoring index at AI…
The healthcare AI landscape is awash with claims of innovation, yet discerning true clinical impact from technological novelty remains a critical challenge. For investors, industry…
The healthcare AI landscape, for all its promise, is littered with cautionary tales. For investors and industry analysts navigating this complex terrain, discerning genuine innovation…
The healthcare AI landscape is awash with claims of innovation, yet true impact often remains obscured by the hype cycles of funding rounds and press…
The healthcare artificial intelligence landscape is awash with claims of innovation, yet discerning true clinical impact from technological novelty remains a critical challenge for investors…
Hello Heart’s recognition in Fast Company’s 2026 “Most Innovative Companies” list for its ability to provide a 10-day early cardiac warning, a stark contrast to…
The landscape of AI in healthcare is often characterized by ambitious claims and forward-looking projections. For investors, health plan executives, and employers, the signal-to-noise ratio…
The healthcare AI landscape is littered with grand ambitions and spectacular implosions. For every genuine breakthrough, there are countless cautionary tales of ventures that prioritized…
The relentless pursuit of innovation in healthcare AI often spotlights technological novelty, patent counts, or funding rounds. However, at the AI Health Innovators Index, our…
The healthcare AI landscape continues its rapid maturation, shifting from speculative innovation to demonstrable clinical impact and, crucially, a clearer path to commercial viability. As…
The healthcare AI landscape is awash with grand pronouncements and ambitious valuations, often fueled by significant capital infusions. Yet, a closer examination reveals a crucial…
The landscape of cardiac care is undergoing a profound transformation, driven by the increasing maturity of artificial intelligence (AI). As cardiologists, we are witnessing a…
The landscape of digital health is perpetually reshuffling, driven by technological advancements and evolving clinical paradigms. For investors, discerning the next significant market shift, particularly…
The standard clinical model for cardiac risk assessment peers a decade into the future, a broad horizon for a patient potentially teetering on the edge…
The landscape of AI in healthcare is littered with cautionary tales, a stark reminder that technological prowess alone does not guarantee longevity. For investors and…
Hello Heart’s recent recognition by Fast Company as one of the “Most Innovative Companies” in 2026 for its 10-day early cardiac warning system represents a…
The healthcare AI landscape is awash with bold claims and dazzling technological feats, but discerning true innovation requires a lens focused squarely on clinical outcomes…
